These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8065233)

  • 1. Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats.
    Fujimura A; Sudoh T; Ebihara A
    Life Sci; 1994; 55(9):707-11. PubMed ID: 8065233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1996 Apr; 97(8):1978-82. PubMed ID: 8621783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subtype 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats.
    Siragy HM; Carey RM
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R1103-7. PubMed ID: 9321892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system modulates renal bradykinin production.
    Siragy HM; Jaffa AA; Margolius HS; Carey RM
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1090-5. PubMed ID: 8898005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of the type-1 angiotensin II receptor in rat adrenal gland.
    Wakamiya R; Kohara K; Hiwada K
    Blood Press Suppl; 1994; 5():109-12. PubMed ID: 7889191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
    Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
    Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
    Nishikimi T; Tani T; Ohmura T; Yamagishi H; Yanagi S; Yoshiyama M; Toda I; Teragaki M; Akioka K; Takeuchi K
    Jpn Circ J; 1995 Nov; 59(11):754-61. PubMed ID: 8747765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.
    Dourish CT; Duggan JA; Banks RJ
    Eur J Pharmacol; 1992 Jan; 211(1):113-6. PubMed ID: 1618259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
    Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
    Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
    Macari D; Bottari S; Whitebread S; De Gasparo M; Levens N
    Eur J Pharmacol; 1993 Nov; 249(1):85-93. PubMed ID: 8282023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between chronic converting enzyme inhibition and AT1 blockade in mRen2 transgenic rats.
    Lantelme P; Lo M; Mullins JJ; Gharib C; Bizollon CA; Sassard J
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):476-81. PubMed ID: 8847862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
    Eur J Pharmacol; 1995 Apr; 277(2-3):223-8. PubMed ID: 7493612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
    Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
    Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
    Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM
    Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.